Turning Science into Products for Growing Companies

SciGro, Inc. supports rapid translation of research and preclinical stage technology into products for
the pharmaceutical, biotechnology, medical diagnostics, and life sciences industries. SciGro principals
combine expertise in a broad range of scientific disciplines, with particular competence in
monoclonal antibodies and cytometric technologies. Their senior level experience in clinical, research,
and biomedical industry settings helps clients create and implement cost- and time-effective product
development strategies. Typical clients include investors, founders, CEOs, and CSOs, as well as
licensing, technology transfer, and business development officers. Services include assistance with
SBIR and STTR grant proposals; opportunity/technology assessment; design of clinical protocols and
effective workflows for research and clinical laboratories; and management of small research reagent
product lines. Clients use SciGro to speed research-to-development transitions, add specialized
expertise, and leverage capabilities of critical personnel while conserving resources and maintaining
focused growth.

Scroll to Top